A detailed history of Corundum Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Corundum Group, Inc. holds 10,654 shares of MRK stock, worth $1.09 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
10,654
Previous 16,979 37.25%
Holding current value
$1.09 Million
Previous $2.1 Million 42.48%
% of portfolio
0.55%
Previous 0.83%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$111.15 - $128.97 $703,023 - $815,735
-6,325 Reduced 37.25%
10,654 $1.21 Million
Q2 2024

Jul 17, 2024

BUY
$123.8 - $132.96 $803,833 - $863,309
6,493 Added 61.92%
16,979 $2.1 Million
Q1 2024

Apr 15, 2024

BUY
$113.24 - $131.95 $146,079 - $170,215
1,290 Added 14.03%
10,486 $1.38 Million
Q4 2023

Jan 23, 2024

SELL
$100.18 - $109.02 $258,965 - $281,816
-2,585 Reduced 21.94%
9,196 $1 Million
Q3 2023

Oct 17, 2023

SELL
$102.95 - $114.33 $131,261 - $145,770
-1,275 Reduced 9.77%
11,781 $1.21 Million
Q2 2023

Jul 21, 2023

SELL
$108.61 - $118.38 $515,680 - $562,068
-4,748 Reduced 26.67%
13,056 $1.51 Million
Q1 2023

Apr 24, 2023

BUY
$102.94 - $114.86 $514,700 - $574,300
5,000 Added 39.05%
17,804 $1.89 Million
Q4 2022

Jan 12, 2023

BUY
$87.44 - $112.11 $402,573 - $516,154
4,604 Added 56.15%
12,804 $1.42 Million
Q3 2022

Oct 18, 2022

BUY
$84.53 - $94.96 $32,290 - $36,274
382 Added 4.89%
8,200 $706,000
Q2 2022

Jul 25, 2022

BUY
$83.49 - $94.64 $75,141 - $85,176
900 Added 13.01%
7,818 $713,000
Q1 2022

May 02, 2022

BUY
$73.51 - $82.4 $116,145 - $130,192
1,580 Added 29.6%
6,918 $568,000
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $47,704 - $59,756
660 Added 14.11%
5,338 $409,000
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $65,587 - $72,129
915 Added 24.32%
4,678 $351,000
Q2 2021

Aug 02, 2021

BUY
$70.31 - $77.77 $41,131 - $45,495
585 Added 18.41%
3,763 $293,000
Q1 2021

May 10, 2021

BUY
$68.86 - $81.11 $6,059 - $7,137
88 Added 2.85%
3,178 $245,000
Q4 2020

Feb 03, 2021

BUY
$71.77 - $79.65 $24,832 - $27,558
346 Added 12.61%
3,090 $253,000
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $200,805 - $227,614
2,744 New
2,744 $217,000
Q2 2020

Aug 06, 2020

SELL
$70.42 - $80.13 $197,528 - $224,764
-2,805 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$63.36 - $87.82 $177,724 - $246,335
2,805 New
2,805 $216,000
Q1 2020

May 06, 2020

SELL
$63.36 - $87.82 $194,008 - $268,904
-3,062 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$77.58 - $87.54 $9,154 - $10,329
118 Added 4.01%
3,062 $278,000
Q3 2019

Nov 01, 2019

BUY
$76.08 - $82.93 $223,979 - $244,145
2,944 New
2,944 $236,000
Q3 2019

Oct 30, 2019

SELL
$76.08 - $82.93 $224,207 - $244,394
-2,947 Closed
0 $0
Q2 2019

Aug 02, 2019

BUY
$69.84 - $81.59 $1,536 - $1,794
22 Added 0.75%
2,947 $247,000
Q1 2019

May 08, 2019

SELL
$69.58 - $79.36 $472,030 - $538,378
-6,784 Reduced 69.87%
2,925 $243,000
Q4 2018

Feb 19, 2019

BUY
$65.24 - $75.71 $633,415 - $735,068
9,709 New
9,709 $742,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Corundum Group, Inc. Portfolio

Follow Corundum Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corundum Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corundum Group, Inc. with notifications on news.